Published in Can J Cardiol on April 01, 2009
Giant left ventricular pseudoaneurysm presenting with hemoptysis. World J Cardiol (2012) 1.13
Post-myocardial infarction giant left ventricular pseudoaneurysm presenting with severe heart failure. World J Cardiol (2012) 0.75
Mechanisms and Clinical Management of Ventricular Arrhythmias following Blunt Chest Trauma. Cardiol Res Pract (2016) 0.75
Left ventricular pseudoaneurysm. J Am Coll Cardiol (1998) 8.81
Surgical treatment of acquired left ventricular pseudoaneurysms. Ann Thorac Surg (2000) 2.23
Ventricular aneurysm due to blunt chest injury. Ann Thorac Surg (1989) 1.29
Delayed rupture of a left ventricular aneurysm after blunt trauma. Am Surg (2005) 0.98
The contribution of non-invasive imaging modalities to the diagnosis of left ventricular pseudoaneurysm. Przegl Lek (2002) 0.91
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet (2010) 9.90
Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. J Clin Oncol (2012) 6.78
Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet (2012) 4.41
Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet (2009) 3.52
MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res (2008) 2.38
Contralesional repetitive transcranial magnetic stimulation for chronic hemiparesis in subcortical paediatric stroke: a randomised trial. Lancet Neurol (2008) 2.10
Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain (2005) 2.03
Short and long latency afferent inhibition in Parkinson's disease. Brain (2003) 2.02
The mechanisms of interhemispheric inhibition in the human motor cortex. J Physiol (2002) 1.92
Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation. Neurorehabil Neural Repair (2003) 1.83
Effect of low-frequency repetitive transcranial magnetic stimulation on interhemispheric inhibition. J Neurophysiol (2005) 1.70
Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation. Blood (2012) 1.67
Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol (2002) 1.67
Absence of integrin αvβ3 enhances vascular leak in mice by inhibiting endothelial cortical actin formation. Am J Respir Crit Care Med (2012) 1.64
Exploring the connectivity between the cerebellum and motor cortex in humans. J Physiol (2004) 1.60
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain (2006) 1.53
N-Methyl-D-Aspartate antagonists in levodopa induced dyskinesia: a meta-analysis. Can J Neurol Sci (2012) 1.49
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep (2002) 1.48
Myoclonus. Continuum (Minneap Minn) (2013) 1.47
Increased motor cortical facilitation and decreased inhibition in Parkinson disease. Neurology (2013) 1.47
Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region. Mov Disord (2010) 1.46
Effective treatment of mouse sepsis with an inhibitory antibody targeting integrin αvβ5. Crit Care Med (2013) 1.44
Clinical Management Updates in Mantle Cell Lymphoma. Oncology (Williston Park) (2016) 1.43
Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor. Ann Thorac Surg (2010) 1.42
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 1.40
Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation. Arch Gen Psychiatry (2002) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
Two phases of short-interval intracortical inhibition. Exp Brain Res (2003) 1.37
Cortical and spinal abnormalities in psychogenic dystonia. Ann Neurol (2006) 1.31
Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve (2006) 1.27
The modified bradykinesia rating scale for Parkinson's disease: reliability and comparison with kinematic measures. Mov Disord (2011) 1.27
Digit somatotopy within cortical areas of the postcentral gyrus in humans. Cereb Cortex (2008) 1.26
Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol (2002) 1.25
Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb Cortex (2007) 1.24
Effects of theta burst stimulation on motor cortex excitability in Parkinson's disease. Clin Neurophysiol (2011) 1.23
Neurodevelopmental outcome after congenital heart surgery: results from an institutional registry. Circulation (2002) 1.21
Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials. Mov Disord (2009) 1.20
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies. J Hematol Oncol (2014) 1.18
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence. Am J Pathol (2012) 1.16
Involvement of the cerebellothalamocortical pathway in Parkinson disease. Ann Neurol (2010) 1.16
The effects of repetitive transcranial magnetic stimulation on cortical inhibition in healthy human subjects. Exp Brain Res (2006) 1.15
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health (2004) 1.15
Intensity-dependent effects of 1 Hz rTMS on human corticospinal excitability. Clin Neurophysiol (2002) 1.15
Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain (2010) 1.14
Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum Brain Mapp (2009) 1.13
Dystonia in complex regional pain syndrome type I. Ann Neurol (2010) 1.13
Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study. Neuropsychopharmacology (2008) 1.12
The role of the corpus callosum in transcranial magnetic stimulation induced interhemispheric signal propagation. Biol Psychiatry (2010) 1.12
Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study. Mov Disord (2009) 1.12
The effects of inhibitory and facilitatory intracortical circuits on interhemispheric inhibition in the human motor cortex. J Physiol (2007) 1.12
Unilateral subdural motor cortex stimulation improves essential tremor but not Parkinson's disease. Brain (2011) 1.11
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine (2002) 1.11
Dysfunctional neural plasticity in patients with schizophrenia. Arch Gen Psychiatry (2008) 1.10
Deep brain stimulation of the ventral intermediate nucleus of the thalamus in medically refractory orthostatic tremor: preliminary observations. Mov Disord (2008) 1.09
Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. Mov Disord (2011) 1.09
Cortical excitability and interhemispheric inhibition after subcortical pediatric stroke: plastic organization and effects of rTMS. Clin Neurophysiol (2010) 1.09
Two phases of interhemispheric inhibition between motor related cortical areas and the primary motor cortex in human. Cereb Cortex (2008) 1.09
Transcranial magnetic stimulation in different current directions activates separate cortical circuits. J Neurophysiol (2010) 1.08
The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease. Cereb Cortex (2009) 1.08
Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Arch Pediatr Adolesc Med (2004) 1.08
Combined scalp-thalamic EEG recording in sleep and epilepsy. Clin Neurophysiol (2002) 1.07
Reduced cerebellar inhibition in schizophrenia: a preliminary study. Am J Psychiatry (2005) 1.05
Interactions between long latency afferent inhibition and interhemispheric inhibitions in the human motor cortex. J Physiol (2005) 1.05
Potentiation of gamma oscillatory activity through repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex. Neuropsychopharmacology (2009) 1.05
Interhemispheric inhibition in distal and proximal arm representations in the primary motor cortex. J Neurophysiol (2007) 1.04
rTMS for suppressing neuropathic pain: a meta-analysis. J Pain (2009) 1.03
Effects of peripheral sensory input on cortical inhibition in humans. J Physiol (2002) 1.03
Neurocardiogenic syncope complicating pediatric transcranial magnetic stimulation. Pediatr Neurol (2008) 1.02
Expanding the phenomenology of benign hereditary chorea: evolution from chorea to myoclonus and dystonia. Mov Disord (2011) 1.01
Digit-specific aberrations in the primary somatosensory cortex in Writer's cramp. Ann Neurol (2009) 1.01
Short interval intracortical inhibition and facilitation during the silent period in human. J Physiol (2007) 1.00
Transcranial magnetic stimulation: a new investigational and treatment tool in psychiatry. J Neuropsychiatry Clin Neurosci (2002) 1.00
The role of the cerebellum in the pathophysiology and treatment of neuropsychiatric disorders: a review. Brain Res Rev (2008) 0.99
Interhemispheric and ipsilateral connections in Parkinson's disease: relation to mirror movements. Mov Disord (2007) 0.99
Movement related potentials and oscillatory activities in the human internal globus pallidus during voluntary movements. J Neurol Neurosurg Psychiatry (2011) 0.98
The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia. Biol Psychiatry (2008) 0.98
An automated method to determine the transcranial magnetic stimulation-induced contralateral silent period. Clin Neurophysiol (2003) 0.98
Involvement of the basal ganglia and cerebellar motor pathways in the preparation of self-initiated and externally triggered movements in humans. J Neurosci (2007) 0.98
The cerebellothalamocortical pathway in essential tremor. Neurology (2003) 0.97
Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Leuk Lymphoma (2015) 0.95
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experience. J Gastroenterol Hepatol (2012) 0.95
Representation of facial muscles in human motor cortex. J Physiol (2005) 0.93
The EEG correlates of the TMS-induced EMG silent period in humans. Neuroimage (2013) 0.93
Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. Can J Neurol Sci (2011) 0.93
The rationale driving the evolution of deep brain stimulation to constant-current devices. Neuromodulation (2014) 0.93
Increased cortical inhibition in persons with schizophrenia treated with clozapine. J Psychopharmacol (2008) 0.92
Identification of arm movements using correlation of electrocorticographic spectral components and kinematic recordings. J Neural Eng (2007) 0.91
Task-dependent intracortical inhibition is impaired in focal hand dystonia. Mov Disord (2005) 0.91
Practice and barriers toward breast self-examination among young Malaysian women. Asian Pac J Cancer Prev (2011) 0.91
Patient Stratification Using Electronic Health Records from a Chronic Disease Management Program. IEEE J Biomed Health Inform (2016) 0.91
Reliability of long-interval cortical inhibition in healthy human subjects: a TMS-EEG study. J Neurophysiol (2010) 0.90
Associated movement disorders in orthostatic tremor. J Neurol Neurosurg Psychiatry (2012) 0.90
Bi-directional interhemispheric inhibition during unimanual sustained contractions. BMC Neurosci (2009) 0.90
Cortical plasticity following nerve transfer in the upper extremity. Hand Clin (2008) 0.90
Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment. Brain (2013) 0.90
Electrophysiological features of myoclonus-dystonia. Mov Disord (2008) 0.89
Involvement of human thalamus in the preparation of self-paced movement. Brain (2004) 0.89
Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Res (2013) 0.89
The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia. PLoS One (2011) 0.89
Effects of short interval intracortical inhibition and intracortical facilitation on short interval intracortical facilitation in human primary motor cortex. J Physiol (2009) 0.88